真迈生物完成4.1亿元B+轮融资;利维能完成3亿元新一轮融资;擎朗智能完成2亿美元D轮融资

2022-11-21
794
552

Author:Zhenmai Biotech completed 410 million yuan of B+round financing; Levi can complete a new round of financing of 300 million yuan; Qinglang Intelligent completed round D financing of 200 million US dollars
Source: iResearch

Introduction:Zhenmai Biotech completed 410 million yuan of B+round financing; Levi can complete a new round of financing of 300 million yuan; Qinglang Intelligent completed round D financing of 200 million US dollars

[Investment and Financing News September 15]Zhenmai Bio is committed to the R&D and manufacturing of upstream technical products in the gene industry, such as gene sequencer and supporting reagents. As a pioneer of the third generation gene sequencing platform in China, the core technology of Zhenmai Biology is single molecule fluorescence sequencing. Recently completed the B+round with a total amount of 410 million yuanfinancing

Levenen is a battery management system developer, committed to new energyautomobileAnd energy storagemarketBattery system research and development, manufacturing, marketing and technical services. Its main products include vehicle battery system, charger, battery management system, energy storage battery system, etc. Recently, 300 million yuan of financing was completed.

Qinglang Intelligent is a R&D and manufacturer of intelligent service robots. It is committed to applying advanced intelligent service robots and artificial intelligence technologies to create efficient, stable, reliable and practical solutions, and help enterprises in all industries around the world improve service efficiency and achieve intelligent upgrading. Recently completed 2YimeiRMB round D financing.

Cross border E-commerce Logistics Investment and Financing News | Zhenmai Bio has completed 410 million yuan of B+round financing; Levi can complete a new round of financing of 300 million yuan; Qinglang Intelligent completed round D financing of 200 million US dollars

(This document isIrinetFor the reprint of exclusive original manuscript, please indicate the source)
The content of the article is created by the author, and the author is responsible for the authenticity, accuracy and legality of the content. Overseadia advocates respecting and protecting intellectual property rights. Without the permission of the author and/or this website, the content of this website may not be copied, reproduced, or used in other ways. If you find that there are copyright issues in the articles on this site, please contact chuhaiyi@baidu.com, and we will verify and deal with them in time. Source of the article: iResearch, this article is the author's independent point of view, and does not represent the position of overseadia.